Skip to main content

Unruptured Cerebral Aneurysm

0
Pipeline Programs
1
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

ARTIRIA Medical
ARTIRIA MedicalSwitzerland - Geneva
1 program
SmartGUIDEN/A3 trials
Active Trials
NCT06972966Recruiting30Est. Dec 2026
NCT06972953Recruiting30Est. Dec 2026
NCT05564325Terminated5Est. Mar 2026

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
ARTIRIA MedicalSmartGUIDE
ARTIRIA MedicalSmartGUIDE
ARTIRIA MedicalSmartGUIDE

Clinical Trials (3)

Total enrollment: 65 patients across 3 trials

NEUROvascular NAVigation With Remotely Controlled Deflectable Guidewire, Study II (NeuroNAV Study II)

Start: Jun 2025Est. completion: Dec 202630 patients
N/ARecruiting

NEUROvascular NAVigation With Remotely Controlled Deflectable Guidewire, Study I (NeuroNAV Study I)

Start: Jun 2025Est. completion: Dec 202630 patients
N/ARecruiting

Real-time Deflectable Guidewire in Neuro-interventions Study

Start: Apr 2023Est. completion: Mar 20265 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 65 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.